Protagonist Therapeutics shares owned by Advantage Alpha Capital Partners
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Advantage Alpha Capital Partners
from 13F filings
Historical chart of Advantage Alpha Capital Partners investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Protagonist Therapeutics by Advantage Alpha Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $386k | 5.8k | 66.43 |
| 2025-06-30 | $385k | 7.0k | 55.27 |
| 2025-03-31 | $418k | 8.6k | 48.36 |
| 2024-12-31 | $222k | 5.7k | 38.60 |
| 2024-09-30 | $510k | 11k | 45.00 |
More positions owned by Advantage Alpha Capital Partners
View all positions for Advantage Alpha Capital Partners